Skip to content
Insider tapeLive · 5:37 PM ET
Watchlist

Troy A. Ignelzi

CFO at Rapport Therapeutics, Inc. (RAPP)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys+$1K
Total bought / sold$144K / $0

Reported trades

Filed Stock Type Shares Price Value Since
Oct 21SEC RAPPRapport Therapeutics, Inc. Buy 5,50015,500 held (+55%) $26.10 $144K +1.0%
  • Buy

    CFO Troy A. Ignelzi bought $144K of RAPP at $26.10 — first open-market purchase in our records; raises the stake by 55%.